Table 2.

Daily combined scores of medication and rhinoconjunctivitis symptoms during the peak pollen period.

	FAS Population		PPS Population
	SLIT	Placebo	SLIT	Placebo
N	421	211	395	195
Mean ± SD	1.46 ± 0.47	1.88 ± 0.42	1.49 ± 0.52	1.95 ± 0.46
P value	<0.0001		<0.0001
Improvement	22.3%		23.6%
Adjusted mean difference (95% CI)	0.371 (0.289–0.453)		0.420 (0.321–0.518)

FAS, full analysis set; PPS, per protocol set; SLIT, sublingual immunotherapy; SAR, seasonal allergic rhinitis; CI, confidence interval